Literature DB >> 34378420

Prevalence and Correlates of Suicidal Ideation and Deliberate Self-harm in Canadian Adolescents During the Coronavirus Disease 2019 Pandemic.

Brianna J Turner1, Christina L Robillard1, Megan E Ames1, Stephanie G Craig2.   

Abstract

OBJECTIVE: In light of recent evidence that the coronavirus disease 2019 (COVID-19) pandemic has resulted in marked increases in depression, anxiety, substance use, and other mental health concerns among Canadian adolescents, we investigated the rates of self-harm thoughts and behaviours in this population. Specifically, this study explored: (1) the demographic and geographic distributions of suicidal ideation (SI) and deliberate self-harm (DSH), and (2) the associations of mental health and substance use with SI and DSH.
METHOD: A total of 809 Canadian adolescents, aged 12-18 years, completed an online survey between June 17, 2020 and July 31, 2020.
RESULTS: 44% of adolescents reported experiencing SI since the pandemic began, while 32% reported engaging in DSH. SI and DSH were more common among youth who: identified as transgender, non-binary or gender fluid; who did not reside with both parents; and who reported psychiatric concerns or frequent cannabis use.
CONCLUSION: Canadian adolescents appear to be experiencing higher rates of self-harm thoughts and behaviours relative to before the COVID-19 pandemic. It is important for adults who are likely to interact with distressed youth to be aware of potential warning signs that a youth is struggling with self-harm, and to refer youth to specialty mental health services where appropriate.

Entities:  

Keywords:  adolescence; child and adolescent psychiatry; self harm; suicide

Mesh:

Year:  2021        PMID: 34378420      PMCID: PMC9065494          DOI: 10.1177/07067437211036612

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


Canadian adolescents reported markedly higher-than-usual rates of anxiety, depression, and substance use during the coronavirus disease 2019 (COVID-19) pandemic. Rates of recent suicidal ideation (SI) reportedly tripled, from 6% to 18%. We aimed to extend knowledge by examining: (1) which adolescents are most vulnerable to SI and (2) whether we observe similar elevations in deliberate self-harm (DSH), defined as intentional self-injury with non-suicidal or suicidal intent. To do so, we assessed demographic and psychiatric correlates of SI and DSH in a convenience sample of Canadian adolescents recruited during the first 4 months of the COVID-19 pandemic.

Method

Adolescents (n = 809; 56% cis-gender female, 74% White, Mage = 15.67, SD = 1.37) were recruited via social media advertisements from June 17, 2020 to July 31, 2020. Most youth (85%, n = 688) who started the online survey completed it, and scale-level missing data were minimal (<1% for all variables except ethnicity [7%] and substance use frequencies [15%]). Recent (past 4-month) conduct problems, oppositionality, attention problems/hyperactivity, depression, anxiety, separation fears, and social anxiety were assessed with the 52-item Ontario Child Health Study Scales (subscale αs = .70–.87). Recent (past 90-day) use of alcohol, cannabis, and illicit drugs (e.g. ecstasy/MDMA, opiates) was measured using the 14-item Drug History Questionnaire. Participants reported whether, during the past 4 months, “I think about killing myself” (SI) or “I deliberately try to hurt or kill myself” (DSH) were “never, or not true” (0), “sometimes, or somewhat true” (1), or “often, or very true” (2). Analyses dichotomized SI and DSH as present (1 or 2) or absent (0). Full study details are available at https://psyarxiv.com/kprd9/.

Results

Our sample closely matched known demographics of Canadian youth, with similar proportions of youth identifying as visible minorities (26% vs 27% ), living in two-parent households (70% in both ), reporting any history of alcohol use (42% vs 44% ) and accessing mental health supports (17% in both ). Higher rates of psychiatric concerns in this sample (e.g. major depression: 50%) versus representative pre-pandemic surveys (11% ) may be attributable to use of a screening measure here versus prior diagnoses. Table 1 summarizes results. One-quarter of adolescents (26%, n = 212) reported both SI and DSH, one in six (17%, n = 139) reported SI only, and one in 20 (5%, n = 43) reported DSH only. There were no regional or racial/ethnic differences in SI or DSH. Transgender/non-binary youth reported more SI and DSH than cis-gender youth, and cis-gender females reported more DSH than cis-gender males. Youth who lived with both parents reported less SI and DSH than youth who lived with a single parent, divided time between multiple households, or did not live with parents.
Table 1.

Rates of SI and DSH by Demographic Group, and Predicted by Psychiatric Concerns or Substance Use Frequency.

Endorsing SI (n = 352)Endorsing DSH (n = 256)
% (n)χ2 (df) P % (n)χ2 (df) P
BC a 47 (55)5.76 (5)0.3333 (29)4.83 (5)0.44
Alberta a 45 (72)35 (56)
Prairies a 46 (41)30 (27)
Ontario a 44 (119)31 (85)
Québec a 30 (20)21 (14)
Atlantic a 43 (42)34 (33)
White b 42 (252)1.63 (1)0.2047 (99)1.19 (1)0.29
Non-White b 31 (183)35 (72)
Boys38 (120)A c : 3.30 (1) B c : 10.74 (1)A c : P = 0.07B c : P = 0.00124 (76)A c : 7.25 (1) B c : 26.74 (1)A c : P = 0.007B c : P< 0.001
Girls45 (204)33 (152)
TNBI68 (28)68 (28)
Living with two parents40 (220)8.82 (1)0.00328 (151)13.76 (1)<0.001
Not living with two parents51 (132)41 (104)
Logistic regression predicting SILogistic regression predicting DSH
Psychiatric concerns OR95% CI of OR P OR95% CI of OR P
 Conduct1.271.14, 142<0.0011.161.05, 1.280.003
 Oppositional0.970.89, 1.060.5141.010.92, 1.100.918
 ADHD0.960.90, 1.030.2720.980.92, 1.050.634
 Anxiety1.191.10, 1.30<0.0011.101.01, 1.200.024
 Depression d 1.341.24, 1.44<0.0011.281.18, 1.38<0.001
 Sep. fears0.980.92, 1.040.4930.980.93, 1.040.554
 Social anxiety1.000.92, 1.080.9981.121.03, 1.210.008
Any elevation (≥1) vs 0 e 6.364.56, 8.88<0.0018.975.45, 14.74<0.001
Logistic regression predicting SILogistic regression predicting DSH
Frequency of substance use OR95% CI of OR P OR95% CI of OR P
 Alcohol1.050.91, 1.210.4851.120.97, 1.290.129
 Cannabis1.331.16, 1.53<0.0011.161.03, 1.310.016
 MDMA0.940.27, 3.250.9171.280.45, 3.640.640
 Opiates1.990.54, 7.270.3010.920.37, 2.250.847
 Prescription1.040.82, 1.310.7551.070.85, 1.350.530
 Nicotine1.050.94, 1.170.3531.030.93, 1.140.622
 Other1.250.83, 1.860.2861.110.79, 1.570.556
Any versus no use1.471.26, 1.71<0.0011.411.18, 1.68<0.001
Any illicit use versus ETOH only1.501.15, 1.960.0021.270.96, 1.690.088

Notes: All logistic regression models controlled for gender (coded as 0 = male, 1 = female or TNBI) and living situation of youth (coded as 0 = residing with both parents, 1 = residing with a single caregiver, multiple households, or with someone other than a biological parent).

TNBI: transgender, non-binary or gender fluid; Sep. fears: separation fears; ETOH: alcohol; SI: suicidal ideation; DSH: deliberate self-harm.

Rates of SI and DSH among participants living in the Territories are not reported due to the small number of respondents (n < 5).

We repeated racial/ethnic contrast excluding respondents who identified as Indigenous, given potentially higher rates of SI and DSH in Indigenous Canadian youth relative to other racial and ethnic minorities and the small number of Indigenous respondents in this sample (n = 54). Results were comparable, indicating that non-Indigenous minority youth had similar rates of SI (44%) and DSH (30%) as non-Indigenous White youth (42% and 31%, respectively; χ2[1] = 0.13, P = 0.72 and χ2[1] = 0.06, P = 0.81).

Contrast A compares cis-gender girls and cis-gender boys. Contrast B compares TNBI youth and cis-gender youth.

Depression is scored based on seven of the nine items of the Ontario Child Health Study Scales, excluding the two items pertaining to suicidal ideation and deliberate self-harm.

We used weighted population norms to identify a clinical cutoff score that most closely matched the population prevalence of the corresponding disorder.

Rates of SI and DSH by Demographic Group, and Predicted by Psychiatric Concerns or Substance Use Frequency. Notes: All logistic regression models controlled for gender (coded as 0 = male, 1 = female or TNBI) and living situation of youth (coded as 0 = residing with both parents, 1 = residing with a single caregiver, multiple households, or with someone other than a biological parent). TNBI: transgender, non-binary or gender fluid; Sep. fears: separation fears; ETOH: alcohol; SI: suicidal ideation; DSH: deliberate self-harm. Rates of SI and DSH among participants living in the Territories are not reported due to the small number of respondents (n < 5). We repeated racial/ethnic contrast excluding respondents who identified as Indigenous, given potentially higher rates of SI and DSH in Indigenous Canadian youth relative to other racial and ethnic minorities and the small number of Indigenous respondents in this sample (n = 54). Results were comparable, indicating that non-Indigenous minority youth had similar rates of SI (44%) and DSH (30%) as non-Indigenous White youth (42% and 31%, respectively; χ2[1] = 0.13, P = 0.72 and χ2[1] = 0.06, P = 0.81). Contrast A compares cis-gender girls and cis-gender boys. Contrast B compares TNBI youth and cis-gender youth. Depression is scored based on seven of the nine items of the Ontario Child Health Study Scales, excluding the two items pertaining to suicidal ideation and deliberate self-harm. We used weighted population norms to identify a clinical cutoff score that most closely matched the population prevalence of the corresponding disorder. Psychiatric concerns accounted for 43% and 33% of the variance in SI and DSH, respectively. Depression, anxiety, and conduct problems were uniquely associated with SI and DSH, and social anxiety was uniquely associated with DSH. Youth with at least one clinically significant psychiatric concern had 6–9 times greater odds of SI and DSH, versus those who scored below all clinical cutoffs. Frequency of substance use accounted for 9% and 4% of the variance in SI and DSH, respectively. Only cannabis use was uniquely associated with SI and DSH, controlling for other substances. Youth with any recent alcohol, cannabis, or illicit drug use had 40% greater odds of SI and DSH than youth who reported no alcohol or drug use. Compared to youth who used alcohol only, youth who used cannabis or illicit drugs reported 50% higher odds of SI.

Discussion

Identifying demographic features associated with self-harm can inform targeted assessment and intervention, while identifying modifiable risk factors such as psychiatric concerns can inform what types of supports may be beneficial. Our results identified gender minority youth and youth in single-parent homes as being at especially high risk of SI and DSH, suggesting a need for additional screening of these potentially vulnerable youth. Moreover, we identified depression, anxiety, conduct problems, and frequent cannabis use as associated with risk of SI and DSH, suggesting the potential value of coupling targeted suicide prevention (e.g. safety planning, lethal means restriction) with interventions for internalizing and externalizing concerns. Several limitations merit consideration. Firstly, convenience samples remain susceptible to self-selection biases and caution must be applied to any survey with unobserved variables influencing participation. Secondly, this study's cross-sectional design prevented comparisons across phases of the pandemic. Thirdly, we did not differentiate DSH with versus without suicidal intent, and so were unable to investigate rates of non-suicidal self-injury. Finally, we note that available data suggest suicide deaths remained steady or slightly declined in the early stages of the pandemic, and trends for suicidal thoughts, non-fatal self-harm, and fatal self-harm often diverge. Ongoing monitoring of population-level indicators across this spectrum of risk is warranted as the pandemic and its aftermath unfold. This study nonetheless augments literature on the well-being of Canadian adolescents during the COVID-19 pandemic and bolsters calls to enhance support for youth in crisis.
  3 in total

1.  Reliability of a drug history questionnaire (DHQ).

Authors:  L C Sobell; E Kwan; M B Sobell
Journal:  Addict Behav       Date:  1995 Mar-Apr       Impact factor: 3.913

2.  Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries.

Authors:  Jane Pirkis; Ann John; Sangsoo Shin; Marcos DelPozo-Banos; Vikas Arya; Pablo Analuisa-Aguilar; Louis Appleby; Ella Arensman; Jason Bantjes; Anna Baran; Jose M Bertolote; Guilherme Borges; Petrana Brečić; Eric Caine; Giulio Castelpietra; Shu-Sen Chang; David Colchester; David Crompton; Marko Curkovic; Eberhard A Deisenhammer; Chengan Du; Jeremy Dwyer; Annette Erlangsen; Jeremy S Faust; Sarah Fortune; Andrew Garrett; Devin George; Rebekka Gerstner; Renske Gilissen; Madelyn Gould; Keith Hawton; Joseph Kanter; Navneet Kapur; Murad Khan; Olivia J Kirtley; Duleeka Knipe; Kairi Kolves; Stuart Leske; Kedar Marahatta; Ellenor Mittendorfer-Rutz; Nikolay Neznanov; Thomas Niederkrotenthaler; Emma Nielsen; Merete Nordentoft; Herwig Oberlerchner; Rory C O'Connor; Melissa Pearson; Michael R Phillips; Steve Platt; Paul L Plener; Georg Psota; Ping Qin; Daniel Radeloff; Christa Rados; Andreas Reif; Christine Reif-Leonhard; Vsevolod Rozanov; Christiane Schlang; Barbara Schneider; Natalia Semenova; Mark Sinyor; Ellen Townsend; Michiko Ueda; Lakshmi Vijayakumar; Roger T Webb; Manjula Weerasinghe; Gil Zalsman; David Gunnell; Matthew J Spittal
Journal:  Lancet Psychiatry       Date:  2021-04-13       Impact factor: 77.056

3.  The 2014 Ontario Child Health Study Emotional Behavioural Scales (OCHS-EBS) Part I: A Checklist for Dimensional Measurement of Selected DSM-5 Disorders.

Authors:  Laura Duncan; Katholiki Georgiades; Li Wang; Jinette Comeau; Mark A Ferro; Ryan J Van Lieshout; Peter Szatmari; Kathryn Bennett; Harriet L MacMillan; Ellen L Lipman; Magdalena Janus; Anna Kata; Michael H Boyle
Journal:  Can J Psychiatry       Date:  2018-10-30       Impact factor: 4.356

  3 in total
  9 in total

1.  Prolonged impact of the COVID-19 pandemic on self-harm hospitalizations in France: A nationwide retrospective observational study.

Authors:  F Jollant; A Roussot; E Corruble; J C Chauvet-Gelinier; B Falissard; Y Mikaeloff; C Quantin
Journal:  Eur Psychiatry       Date:  2022-06-13       Impact factor: 7.156

2.  [Suicidal attempt and suicidal ideation during the COVID-19 pandemic compared to previous years].

Authors:  Miguel A Jerónimo; Sergio Piñar; Pilar Samos; Ana M Gonzalez; Magda Bellsolà; Agnès Sabaté; Jordi León; Xavier Aliart; Luis M Martín; Rosa Aceña; Victor Pérez; David Córcoles
Journal:  Rev Psiquiatr Salud Ment       Date:  2021-11-19       Impact factor: 3.318

Review 3.  Changes in Youth Mental Health, Psychological Wellbeing, and Substance Use During the COVID-19 Pandemic: A Rapid Review.

Authors:  Sarah Larney; Dennis C Wendt; Camille Zolopa; Jacob A Burack; Roisin M O'Connor; Charlotte Corran; Jessica Lai; Emiliana Bomfim; Sarah DeGrace; Julianne Dumont
Journal:  Adolesc Res Rev       Date:  2022-02-26

4.  Childhood Trauma and Non-suicidal Self-Injury Among Chinese Adolescents: The Mediating Role of Psychological Sub-health.

Authors:  Cui Huang; Qiuyu Yuan; Menglin Ge; Xuanlian Sheng; Meng Yang; Shengya Shi; Panpan Cao; Mengting Ye; Ran Peng; Ruochen Zhou; Kai Zhang; Xiaoqin Zhou
Journal:  Front Psychiatry       Date:  2022-02-10       Impact factor: 4.157

5.  The potential impact of Covid-19 on CNS and psychiatric sequels.

Authors:  Ali Dehghani; Elham Zokaei; Seyyed Mohammad Kahani; Elaheh Alavinejad; Mohammad Dehghani; Gholam Hossein Meftahi; Mohammad Reza Afarinesh
Journal:  Asian J Psychiatr       Date:  2022-04-05

6.  Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders.

Authors:  Claus Wolff-Menzler; Michael Belz; Claudia Bartels; Philipp Hessmann; Ulrike Schmidt; Jonathan Vogelgsang; Mirjana Ruhleder; Alexander Kratzenberg; Marit Treptow; Thorgund Reh-Bergen; Mona Abdel-Hamid; Luisa Heß; Miriam Meiser; Jörg Signerski-Krieger; Katrin Radenbach; Sarah Trost; Björn H Schott; Jens Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-11-25       Impact factor: 5.760

Review 7.  The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review.

Authors:  Claudio Brasso; Silvio Bellino; Cecilia Blua; Paola Bozzatello; Paola Rocca
Journal:  Biomedicines       Date:  2022-03-25

8.  Stressful life events and non-suicidal self-injury among Chinese adolescents: A moderated mediation model of depression and resilience.

Authors:  Chang Wei; Zhiyong Li; Tao Ma; Xiaxia Jiang; Chengfu Yu; Qian Xu
Journal:  Front Public Health       Date:  2022-08-04

9.  Longitudinal Correlates of Suicide Ideation in People who use Drugs during the COVID-19 Pandemic.

Authors:  Kasey Claborn; Elizabeth Lippard; Fiona Conway
Journal:  Res Sq       Date:  2022-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.